May 30, 2013
A New Jersey federal judge on Wednesday allowed a class of Merck & Co. Inc. investors to tweak its securities fraud suit against the drugmaker for a sixth time but barred the inclusion of a 2004 news article, finding it didn't provide any new information about Merck's alleged knowledge of the possible risks of its painkiller Vioxx.
January 31, 2013
A New Jersey federal judge on Wednesday certified a class of Merck & Co. Inc. investors who've claimed for years that company executives artificially boosted the drugmaker's stock price by concealing evidence that its arthritis painkiller Vioxx had been linked to heart attack risks.
November 09, 2011
Merck & Co. Inc. on Tuesday said it had agreed to a $49.5 million settlement in a class action alleging its employees' savings plans took a hit from the company's misrepresentations about the health risks associated with its former prescription painkiller Vioxx.